Function — Annual access to 100+ lab tests with doctor insights
Function is a platform that provides patients with access to over 100 lab tests at a single annual cost of $499. It aims to remove barriers around extensive lab testing and empower individuals to take control of their health. The company also provides comprehensive, actionable insights from top doctors and thousands of hours of research, aiming to help members become their greatest advocates.
Get it by email
Companies like Function go out every weekday morning. One-click unsubscribe.
- Round
- $450M
- Investors
- General Catalyst
- Sectors
- Healthcare
- Logged
- July 30, 2026, in issue #1
- Website
- www.functionhealth.com
More in healthcare
$100M Series C · delixtherapeutics.com
Delix Therapeutics — Non-hallucinogenic psychedelic drugs for mental health
Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.
BiotechnologyData and analyticsHealthcareSV Health neurodegen fundStrategic Pharma$100M+ · +1 · +4
$4.7M Seed · getpeppermint.ai
Peppermint — Billing and collections for clinical trial sites
Peppermint is a software company based in San Francisco that focuses on AI-powered financial operations for clinical research teams. It aims to modernize the financial infrastructure used by hospital systems and research sites to manage clinical trials. Founded in 2026, the company provides a platform that automates billing, invoicing, and collections. This platform integrates with existing clinical trial management systems to streamline revenue cycle management.
BiotechnologySoftwareHealthcareEvan MooreBenjamin MannNight Capital · +8 · +11
$22M Series B · ozlosleep.com
Ozlo — Noise-masking sleepbuds built for all-night comfort
Ozlo is a sleep technology company behind Ozlo Sleepbuds, wearable devices designed for all-night comfort using intelligent noise masking. The company has surpassed 260,000 customers in under two years and is expanding beyond Sleepbuds into new areas of sleep and nighttime health. Ozlo is advancing regulatory work for a tinnitus product and building a broader ecosystem of products powered by biosensing, AI, and neuromodulation. The company partners with major institutions, elite athletes, and sleep clinics to address wellness, performance, and clinical demands.
HealthcareArtificial intelligenceLifeArcArtis VenturesResmedScrum Ventures · +12 · +15
General Catalyst also backed Nooks, Hyperbolic, Baba and 16 more we logged